Appropriate calibration curve fitting in ligand binding assays
暂无分享,去创建一个
[1] Karpinski Kf,et al. Optimality assessment in the enzyme-linked immunosorbent assay (ELISA). , 1990 .
[2] W C Smith,et al. Conceptual and statistical issues in the validation of analytic dilution assays for pharmaceutical applications. , 1998, Journal of biopharmaceutical statistics.
[3] David M. Rocke,et al. Optimal design for ELISA and other forms of immunoassay , 1997 .
[4] K F Karpinski,et al. Optimality assessment in the enzyme-linked immunosorbent assay (ELISA). , 1990, Biometrics.
[5] Krys J. Miller,et al. Workshop on Bioanalytical Methods Validation for Macromolecules: Summary Report , 2001, Pharmaceutical Research.
[6] A Yacobi,et al. Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies , 1991, European Journal of Drug Metabolism and Pharmacokinetics.
[7] D. J. Finney,et al. The Form and Estimation of a Variance Function, with Particular Reference to Radioimmunoassay , 1977 .
[8] P. Gottschalk,et al. The five-parameter logistic: a characterization and comparison with the four-parameter logistic. , 2005, Analytical biochemistry.
[9] D Rodbard,et al. Statistical analysis of radioligand assay data. , 1975, Methods in enzymology.
[10] Binodh DeSilva,et al. Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of Macromolecules , 2003, Pharmaceutical Research.
[11] D. Rodbard,et al. [1] Statistical analysis of radioligand assay data , 1975 .
[12] H. T. Karnes,et al. Calibration and validation of linearity in chromatographic biopharmaceutical analysis. , 1991, Journal of pharmaceutical and biomedical analysis.
[13] D. J. Finney. Statistical Method in Biological Assay , 1966 .
[14] Sidney Addelman,et al. trans-Dimethanolbis(1,1,1-trifluoro-5,5-dimethylhexane-2,4-dionato)zinc(II) , 2008, Acta crystallographica. Section E, Structure reports online.
[15] D. J. Finney,et al. Guidelines for immunoassay data processing. , 1985, Clinical chemistry.
[16] Thomas Layloff,et al. Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies , 1992, Pharmaceutical Research.
[17] D. Ruppert,et al. Transformation and Weighting in Regression , 1988 .
[18] Vinod P. Shah,et al. Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays , 2007 .
[19] Vinod P. Shah,et al. Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays , 2007 .
[20] M C Haven,et al. Data-reduction methods for immunoradiometric assays of thyrotropin compared. , 1987, Clinical chemistry.
[21] J. W. Findlay,et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. , 2000, Journal of pharmaceutical and biomedical analysis.
[22] Robert Singer,et al. Bioassay Glossary , 2006 .
[23] Vinod P. Shah,et al. Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays , 2007, The AAPS Journal.
[24] Vinod P. Shah,et al. Bioanalytical Method Validation—A Revisit with a Decade of Progress , 2000, Pharmaceutical Research.